| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | CleanTech • HealthTech (& Fitness) • Impact • Medical Devices (& Hospital Services) • Life Science • Online Social • Pharmaceutical (& Medicine) • Diagnostics |
| Stages | Seed, Series A |
| Investing | United States • France • China • Singapore |
| Investment Range | $100,000 - $5,000,000 |
Nest.Bio Ventures is a venture capital firm based in Cambridge, Massachusetts, specializing in the biotechnology and therapeutics sector. Focused on nurturing innovation and entrepreneurial spirit in the life sciences domain, Nest.Bio Ventures plays a pivotal role in transforming visionary ideas into reality across North America and Asia.
By providing both financial investment and a nurturing environment, they help early-stage biotech startups to scale new heights.
Founded with a mission to hatch revolutionary biotech ventures, they extend their expertise and resources to pioneering founders, aiding in the development, funding, and commercialization of cutting-edge technologies. A distinct feature of Nest.Bio Ventures is their Nest.Bio Labs, which offer shared and private lab spaces, office spaces, and a collaborative community network to foster the growth of resident companies.
Since opening its doors in 2018, Nest.Bio Labs has been instrumental in creating local jobs, boasting over 1,029 jobs generated by resident companies. The ecosystem they have built comprises 36 companies in the resident and graduate community, amassing a combined market capitalization value exceeding $7 billion. Nest.Bio Ventures and their incubator stand out with their strategic location in Cambridge, near Kendall Square, which is known for its vibrant life science innovation hub.
With flexible leasing options for their private and shared lab spaces, Nest.Bio Ventures goes beyond funding; they offer a holistic approach to company growth in the biotech sector, aligning scientific accomplishments with business success.
We employ a cross-border strategy to support the commercialization of scientific discoveries.
What we look for: We invest in companies translating breakthrough deep science into revolutionary ventures, with a focus on biotechnology and life sciences that impact health.










